BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34991592)

  • 1. Bacterial infections exacerbate myeloma bone disease.
    Liu R; Zhong Y; Chen R; Chen S; Huang Y; Liu H
    J Transl Med; 2022 Jan; 20(1):16. PubMed ID: 34991592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis
    Yang J; Tang R; Yi J; Chen Y; Li X; Yu T; Fei J
    FASEB J; 2019 Jun; 33(6):7261-7273. PubMed ID: 30857415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.
    Zhu X; Gao J; Ng PY; Qin A; Steer JH; Pavlos NJ; Zheng MH; Dong Y; Cheng TS
    J Bone Miner Res; 2016 Mar; 31(3):560-72. PubMed ID: 26363136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.
    Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D
    Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma.
    Liu H; Liu Z; Du J; He J; Lin P; Amini B; Starbuck MW; Novane N; Shah JJ; Davis RE; Hou J; Gagel RF; Yang J
    Sci Transl Med; 2016 Aug; 8(353):353ra113. PubMed ID: 27559096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
    Hsieh TP; Sheu SY; Sun JS; Chen MH
    Phytomedicine; 2011 Jan; 18(2-3):176-85. PubMed ID: 20554188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells.
    Tsubaki M; Seki S; Takeda T; Chihara A; Arai Y; Morii Y; Imano M; Satou T; Shimomura K; Nishida S
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma.
    Heath DJ; Vanderkerken K; Cheng X; Gallagher O; Prideaux M; Murali R; Croucher PI
    Cancer Res; 2007 Jan; 67(1):202-8. PubMed ID: 17210700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.
    Boissy P; Andersen TL; Abdallah BM; Kassem M; Plesner T; Delaissé JM
    Cancer Res; 2005 Nov; 65(21):9943-52. PubMed ID: 16267019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Licorice isoliquiritigenin-encapsulated mesoporous silica nanoparticles for osteoclast inhibition and bone loss prevention.
    Sun X; Zhang J; Wang Z; Liu B; Zhu S; Zhu L; Peng B
    Theranostics; 2019; 9(18):5183-5199. PubMed ID: 31410209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways.
    He Y; Zhang Q; Shen Y; Chen X; Zhou F; Peng D
    Biochem Biophys Res Commun; 2014 Jul; 449(3):344-50. PubMed ID: 24845381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth.
    Feng R; Anderson G; Xiao G; Elliott G; Leoni L; Mapara MY; Roodman GD; Lentzsch S
    Blood; 2007 Mar; 109(5):2130-8. PubMed ID: 17095620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lanthanum Chloride Attenuates Osteoclast Formation and Function Via the Downregulation of Rankl-Induced Nf-κb and Nfatc1 Activities.
    Jiang C; Shang J; Li Z; Qin A; Ouyang Z; Qu X; Li H; Tian B; Wang W; Wu C; Wang J; Dai M
    J Cell Physiol; 2016 Jan; 231(1):142-51. PubMed ID: 26060084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease.
    Pennisi A; Li X; Ling W; Khan S; Gaddy D; Suva LJ; Barlogie B; Shaughnessy JD; Aziz N; Yaccoby S
    Br J Haematol; 2009 Jun; 145(6):775-87. PubMed ID: 19388929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice.
    Shao S; Fu F; Wang Z; Song F; Li C; Wu ZX; Ding J; Li K; Xiao Y; Su Y; Lin X; Yuan G; Zhao J; Liu Q; Xu J
    J Cell Physiol; 2019 Aug; 234(8):12701-12713. PubMed ID: 30515812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
    J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway.
    Zheng L; Gao J; Jin K; Chen Z; Yu W; Zhu K; Huang W; Liu F; Mei L; Lou C; He D
    FASEB J; 2019 Jun; 33(6):7667-7683. PubMed ID: 30893559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts.
    Zhang T; Han W; Zhao K; Yang W; Lu X; Jia Y; Qin A; Qian Y
    FASEB J; 2019 Apr; 33(4):5399-5410. PubMed ID: 30702934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.